Forbion Capital Fund IV Cooperatief U.A. - 08 Aug 2025 SCHEDULE 13D/A Report for NewAmsterdam Pharma Company N.V. Ordinary Shares, Nominal value 0.12 per share (NAMS)

Filing Manager: Forbion Capital Fund IV Cooperatief U.A.
Reporting Manager: ForGrowth NAP B.V.
Security: NewAmsterdam Pharma Company N.V. Ordinary Shares, Nominal value 0.12 per share
Symbol: NAMS
Shares outstanding: 112,540,489 shares
Disclosed Ownership: 10,578,806 shares
Ownership: 9.4%
Form type: SCHEDULE 13D/A
Filing time: 12 Aug 2025, 16:30:25 UTC
Date of event: 08 Aug 2025
Next filing: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (5)

Name	Ownership	Shares Owned	shared voting power	Signature	Title	CIK
Forbion Capital Fund IV Cooperatief U.A.	5.3%	5,930,781	5,930,781	/s/ V. van Houten /s/ G.J. Mulder	V. van Houten and G.J. Mulder, Directors of its Director	0001823747
Forbion IV Management B.V.	5.3%	5,930,781	5,930,781	/s/ V. van Houten /s/ G.J. Mulder	V. van Houten and G.J. Mulder, Directors
Forbion Growth Opportunities Fund I Cooperatief U.A.	4.1%	4,648,025	4,648,025	/s/ V. van Houten /s/ G.J. Mulder	V. van Houten and G.J. Mulder, Directors of its Director
Forbion Growth Management B.V.	4.1%	4,648,025	4,648,025	/s/ V. van Houten /s/ G.J. Mulder	V. van Houten and G.J. Mulder, Directors
ForGrowth NAP B.V.	9.4%	10,578,806	10,578,806	/s/ V. van Houten /s/ G.J. Mulder	V. van Houten and G.J. Mulder, Directors of its Director